Header image
Škrott Zdeněk Ph.D.
About me
Junior researcher in cellular biology and translational medicine, with ample experience in conducting and managing independent scientific projects. I am actively developing my own research program focused on the cellular response to proteotoxic stress and new techniques.
Author of 16 original scientific publications with over 1000 SCI citations. H-index 11
Journals
A phase 1/2 study of disulfiram and copper with concurrent radiation therapy and temozolomide for patients with newly diagnosed glioblastoma. International Journal of Radiation Oncology, Biology, Physics. 2024, 120(3), 738-749, ISSN: 0360-3016, PMID: 38768767,
Identification of novel dithiocarbamate-copper complexes targeting p97/NPL4 pathway in cancer cells. European Journal of Medicinal Chemistry. 2023, 261, 115790, ISSN: 0223-5234 , PMID: 37690264,
Actionable cancer vulnerability due to translational arrest, p53 aggregation and ribosome biogenesis stress evoked by the disulfiram metabolite CuET. Cell Death and Differentiation. 2023, ISSN: 1350-9047, PMID: 37142656,
Bachelor mentorship
Kamrlová Tereza
Targeting proteotoxic and genotoxic in cancer cells
Status: Ongoing from 2025.
Open positions
1 Molecular and Translational Medicine
| Project: | Cellular stress in health and disease |
|---|---|
| Supervisors: | Mistrík Martin Ph.D., Moudrý Pavel Ph.D., Škrott Zdeněk Ph.D. |
| Available: | 3 |
| Intended for: | Doctoral training |